Cerevel Therapeutics Hldng I shares owned by Frazier Life Sciences Management
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Frazier Life Sciences Management
from 13F filings
Historical chart of Frazier Life Sciences Management investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Frazier Life Sciences Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17M | 393k | 42.40 |
| 2023-09-30 | $8.6M | 393k | 21.83 |
| 2023-06-30 | $13M | 393k | 31.79 |
| 2023-03-31 | $9.6M | 393k | 24.39 |
| 2022-12-31 | $12M | 393k | 31.54 |
| 2022-09-30 | $11M | 393k | 28.26 |
| 2022-06-30 | $5.3M | 202k | 26.44 |
| 2022-03-31 | $2.0M | 56k | 35.01 |
More positions owned by Frazier Life Sciences Management
View all positions for Frazier Life Sciences Management